Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study

Conclusions: About half of a selected sample of children with NS met criteria for catatonia. Catatonia scores decreased in most patients after one or two doses of lorazepam. Larger, longer, and controlled studies are warranted to assess the prevalence of catatonia in NS and to assess the use of lorazepam in NS through its effects on catatonia.Trial Registration: ClinicalTrials.gov NCT02462109Date of formal registration: June 2, 2015

http://www.biomedcentral.com/1756-0500/8/825

Source: Epidemiologic Perspectives and Innovations - December 28, 2015 Category: Epidemiology Authors: Angelina Kakooza-MwesigeDirk DhosscheRichard IdroDickens AkenaJoyce NalugyaBenard Opar Source Type: research